1110. A multicenter Evaluation of Outcomes Associated With Oral Vancomycin Dose in Patients With Clostridium difficile Infection

BACKGROUND: Clostridium difficile infection (CDI) is a significant cause of morbidity and mortality. IDSA guidelines recommend oral vancomycin (VAN) for the treatment of CDI, although doses used in practice vary substantially. The purpose of this study was to determine differences in outcomes betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidell, Monique, Novak, Gregory, Singh, Gurkirat, Bratek, Benjamin, Duru, Odirichukwu, Mitchell, Colby, O’Donnell, J Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254310/
http://dx.doi.org/10.1093/ofid/ofy210.944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254310/
http://dx.doi.org/10.1093/ofid/ofy210.944

Ejemplares similares